Ravinder Heights Share Price

Ravinder Heights Limited was incorporated on April 15, 2019 as a wholly owned subsidiary of Panacea Biotec Limited. The Company is engaged in the business of the Real Estate. It undertake the business of acquisition, construction, development of townships builtup infrastructure, housing, commercial premises, hotels, resorts, hospital, educational institution, recreational facilities, city and regional level infrastructure. In 201920, the Real Estate Business Undertaking of Panacea Biotec Limited got demerged with and into the Company as a going concern basis, through the Scheme of Arrangement in December, 2020. Accordingly, the Shareholders of Panacea Biotec Limited were allotted one fully paidup equity share of Re. 1/ each in the Company, for every one fully paidup equity share of Re. 1/ each held by them in Panacea Biotec Limited. Simultaneously, the Company ceased to be a subsidiary of Panacea Biotec Limited.

Ravinder Heights reported a Q2 FY 2025-26 revenue of ₹55.01 crore, down -27.0% YoY, with net profit increased 18.1% to ₹39.87 crore. For the full year FY2025–2026, revenue reached ₹7.21 crore and profit touched at ₹-2.54 crore.

As of 7 Dec 2025, Ravinder Heights share price is ₹56. The stock opened at ₹55.5 and had closed at ₹55.2 the previous day. During today’s trading session, Ravinder Heights share price moved between ₹54.90 and ₹56.05, with an average price for the day of ₹55.47. Over the last 52 weeks, the stock has recorded a low of ₹38.15 and a high of ₹81.90. In terms of performance, Ravinder Heights share price has increased by 2.5% over the past six months and has declined by 21.54% over the last year.